Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2020 | Story Dr Nitha Ramnath | Photo Supplied
Devina Harry Kader Asmal Fellowship
The UFS’ Devina Harry was accepted into the Kader Asmal Fellowship Programme.

The UFS’ own Devina Harry is set to travel to Ireland in September 2020 to begin a year-long Fellowship Programme for a Master of Business. As one of 20 students selected from the African continent, Devina was recently accepted into the Kader Asmal Fellowship Programme, which affords her the opportunity to study in Ireland during the 2020/21 academic year.

A research assistant in the Department of Business Management, Devina holds an Honours in Marketing. “I am very grateful to be awarded this scholarship and excited about this new journey,” says Devina, who is scheduled to begin the programme in October 2020. “I hope to come back to South Africa and contribute to my field of study,” she says.

Devina went through a rigorous application process and had to meet the criteria for selection, one of which is having a minimum average grade point of 75% for her honours.

Prof Brownhilder Nene, Head of Department: Business Management, gave Devina some words of encouragement: “You will never know how far you can go unless you try. Thank you, Devina, for stepping out of your comfort zone and getting this scholarship.” 

The Kader Asmal Fellowship Programme is a South African strand of a broader Ireland-Africa Fellows Programme managed by the Irish Department of Foreign Affairs and Trade. It was set up in 2012 in honour of the late Professor Kader Asmal, and is a fully-funded scholarship opportunity for those who want to develop skills and knowledge to contribute to the achievement of the Sustainable Development Goals in South Africa.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept